TrialSpark partners with Limbix for digital therapy clinical trial

By Staff Reporter

- Last updated on GMT

(Image: Getty/Unomat)
(Image: Getty/Unomat)

Related tags: Clinical trial, Digital therapeutic, TrialSpark, Limbix

In the company’s latest partnership, TrialSpark has partnered with Limbix to design and implement a clinical trial for a digital therapeutic for adolescent depression.

Digital health companies are developing in scale, as greater amounts of venture capital funding enters the sector​.

TrialSpark, a technology-focused developer of clinical trials, has utilized this interest to sign another clinical trial partnership agreement with Limbix, which follows shortly on from a similar deal with 23andMe​ and, prior to that, Pfizer.

The latest collaboration will see the two companies partner to plan and instigate a clinical trial for Limbix Spark, which uses mobile and virtual reality (VR) technology to treat adolescent depression.

Limbix Spark itself is a five-week program that uses cognitive behavioral therapy to help teenagers identify behaviors and activities that can influence their mood positively.

TrialSpark will bring the digital therapeutic to doctors through its clinical trial sites, which can recruit patients to fit enrollment criteria for Limbix’s trial of its technology through the use of anonymized, aggregated data of potential patients.

Jeff Yuan, head of client growth at TrialSpark, commented that the company’s network of community physicians allows direct feedback on trials, as well as allowing the digital therapeutic to reach “diverse geographies”​ that would usually not gain access to such treatments.

Related news

Show more

Related products

show more

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us


View more